Crossmark

Effectiveness, safety, and major adverse limb events in atrial fibrillation patients with concomitant diabetes mellitus treated with non-vitamin K antagonist oral anticoagulants

Crossref DOI link: https://doi.org/10.1186/s12933-020-01043-2

Published Online: 2020-05-13

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Chan, Yi-Hsin

Lee, Hsin-Fu

Li, Pei-Ru

Liu, Jia-Rou

Chao, Tze-Fan

Wu, Lung-Sheng

Chang, Shang-Hung

Yeh, Yung-Hsin

Kuo, Chi-Tai

See, Lai-Chu

Lip, Gregory Y. H.
License Information

Text and Data Mining valid from 2020-05-13

Version of Record valid from 2020-05-13
More Information

Article History

Received: 26 February 2020

Accepted: 9 May 2020

First Online: 13 May 2020

Ethics approval and consent to participate

: The study protocol complies with the Declaration of Helsinki and was approved by the Institutional Review Board of the Chang Gung Medical Foundation.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below